Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer

Tekijä Patel, Shiven B, Gill, David, Garrido-Laguna, Ignacio
Julkaisussa Onco Targets Ther (2015)

Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care?

Tekijä Chalmers, Anna W., Patel, Shiven B., Akerley, Wallace
Julkaisussa J Thorac Dis (2018)

Combination of Local Ablative Therapy and Continuation of Immune Checkpoint Inhibitor (ICI) Therapy Provides Durable Treatment Response Past Oligometastatic Progression in NSCLC: A...

Tekijä Griswold, Cassia R., Kerrigan, Katie, Patel, Shiven B.
Julkaisussa Case Rep Oncol (2019)

Prognostic Significance of Patient-Reported Outcomes in Cancer

Tekijä Kerrigan, Kathleen, Patel, Shiven B., Haaland, Benjamin, Ose, Dominik, Weinberg Chalmers, Anna, Haydell, Tyler, Meropol, Neal J., Akerley, Wallace
Julkaisussa JCO Oncol Pract (2020)

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma

Tekijä Kuzman, James A., Stenehjem, David D., Merriman, Joseph, Agarwal, Archana M., Patel, Shiven B., Hahn, Andrew W., Alex, Anitha, Albertson, Dan, Gill, David M., Agarwal, Neeraj
Julkaisussa BMC Urol (2017)

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

Tekijä Tantravahi, Srinivas K., Albertson, Daniel, Agarwal, Archana M., Ravulapati, Sowmya, Poole, Austin, Patel, Shiven B., Hawatmeh, Jamil S., Straubhar, Alli M., Liu, Ting, Stenehjem, David D., Agarwal, Neeraj
Julkaisussa J Oncol (2015)